Costigan et al. reported a high correlation (p < 0.0001) of exon 3 mutations identified by sequencing with the beta-catenin redistribution into the cell nucleus detected by immunohistochemistry in endometrial cancer. This evidence concerns the gene CTNNB1 and endometrial cancer.